SG11201907220UA - Probe combination for detection of cancer - Google Patents

Probe combination for detection of cancer

Info

Publication number
SG11201907220UA
SG11201907220UA SG11201907220UA SG11201907220UA SG11201907220UA SG 11201907220U A SG11201907220U A SG 11201907220UA SG 11201907220U A SG11201907220U A SG 11201907220UA SG 11201907220U A SG11201907220U A SG 11201907220UA SG 11201907220U A SG11201907220U A SG 11201907220UA
Authority
SG
Singapore
Prior art keywords
probes
international
targeting
taiwan
dist
Prior art date
Application number
SG11201907220UA
Other languages
English (en)
Inventor
You-Yu Lin
ya-chun Wang
Sheng-Tai Tzeng
Original Assignee
Tcm Biotech Int Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tcm Biotech Int Corp filed Critical Tcm Biotech Int Corp
Publication of SG11201907220UA publication Critical patent/SG11201907220UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201907220UA 2017-02-07 2018-02-06 Probe combination for detection of cancer SG11201907220UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762456087P 2017-02-07 2017-02-07
PCT/CN2018/075474 WO2018145627A1 (en) 2017-02-07 2018-02-06 Probe combination for detection of cancer

Publications (1)

Publication Number Publication Date
SG11201907220UA true SG11201907220UA (en) 2019-09-27

Family

ID=63038710

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907220UA SG11201907220UA (en) 2017-02-07 2018-02-06 Probe combination for detection of cancer

Country Status (9)

Country Link
US (1) US11319602B2 (de)
EP (1) EP3580353B1 (de)
JP (1) JP6799175B2 (de)
KR (1) KR102327119B1 (de)
CN (1) CN110573628B (de)
ES (1) ES2961464T3 (de)
SG (1) SG11201907220UA (de)
TW (1) TWI726191B (de)
WO (1) WO2018145627A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019099629A1 (en) * 2017-11-17 2019-05-23 Gen-Probe Incorporated COMPOSITIONS AND METHODS FOR DETECTING C1orf43 NUCLEIC ACID
US20210207229A1 (en) * 2018-07-27 2021-07-08 Seekln, Inc. Hepatocellular carcinoma screening
KR20200054430A (ko) * 2018-11-09 2020-05-20 주식회사 셀레믹스 폐암 조직 내 세포 유래 돌연변이를 검출하기 위한 프로브 제조 및 검출 방법
WO2021046655A1 (en) * 2019-09-13 2021-03-18 University Health Network Detection of circulating tumor dna using double stranded hybrid capture
KR102446184B1 (ko) * 2019-11-04 2022-09-22 가톨릭대학교 산학협력단 B형 간염 바이러스 검출용 프로브 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100647277B1 (ko) * 2003-08-14 2006-11-17 삼성전자주식회사 Ｂ형 간염 검사용 ｐｃｒ 프라이머 세트 및 이를 포함하는 ｂ형 간염 검사 키트
US20060057670A1 (en) 2004-09-10 2006-03-16 The Chinese University Of Hong Kong Genomic markers of hepatitis B virus associated with hepatocellular carcinomas
US20070042388A1 (en) * 2005-08-12 2007-02-22 Wong Christopher W Method of probe design and/or of nucleic acids detection
EP2205617A4 (de) 2007-11-06 2013-10-16 Siemens Healthcare Diagnostics Hepatitis-b-virus-spezifische oligonukleotidsequenzen
KR101162088B1 (ko) 2008-09-30 2012-07-04 재단법인서울대학교산학협력재단 실시간 ｐｃｒ을 이용하여 ｂ형 간염유래 간질환을 진단하기 위한 키트
CN102277448B (zh) 2011-05-30 2013-09-04 厦门艾德生物医药科技有限公司 用于预测乙肝病毒引起的肝癌的引物、探针及试剂盒
WO2013075313A1 (zh) 2011-11-24 2013-05-30 深圳华大基因科技有限公司 一种检测病毒在待测样本中整合方式的探针及其制备方法和应用
CN103797130B (zh) 2011-06-24 2016-07-27 深圳华大基因科技有限公司 用于确定人体具有异常状态的系统和方法
KR20130121283A (ko) * 2012-04-27 2013-11-06 (주)바이오니아 Ｂ형 간염 바이러스를 검출하기 위한 중합효소연쇄반응의 프라이머, 프로브, 및 이를 이용한 검출키트 및 방법
CN103725773B (zh) * 2012-10-10 2015-11-25 杭州普望生物技术有限公司 鉴定宿主基因组中hbv基因整合位点和重复靶基因
US9840742B2 (en) 2014-06-16 2017-12-12 JBS Science Inc. Detection of hepatitis B virus (HBV) DNA and methylated HBV DNA in urine of patients with HBV-associated hepatocellular carcinoma
CN105506065A (zh) * 2014-09-25 2016-04-20 上海人类基因组研究中心 肝癌基因检测方法、检测试剂盒及其应用
CN106319065B (zh) * 2016-09-14 2020-03-10 上海思路迪医学检验所有限公司 基于高通量测序检测人brca1/2基因的捕获探针及试剂盒
TWI797095B (zh) * 2016-10-24 2023-04-01 美商格瑞爾有限責任公司 腫瘤檢測之方法及系統

Also Published As

Publication number Publication date
CN110573628A (zh) 2019-12-13
US20180223380A1 (en) 2018-08-09
TW201833332A (zh) 2018-09-16
WO2018145627A1 (en) 2018-08-16
US11319602B2 (en) 2022-05-03
TWI726191B (zh) 2021-05-01
KR102327119B1 (ko) 2021-11-16
EP3580353A4 (de) 2020-03-04
JP2020503067A (ja) 2020-01-30
JP6799175B2 (ja) 2020-12-09
KR20190114989A (ko) 2019-10-10
ES2961464T3 (es) 2024-03-12
EP3580353A1 (de) 2019-12-18
EP3580353B1 (de) 2023-09-13
CN110573628B (zh) 2023-12-22

Similar Documents

Publication Publication Date Title
SG11201907220UA (en) Probe combination for detection of cancer
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201809912UA (en) Hybrid carriers for nucleic acid cargo
SG11201803169WA (en) Cellulase variants and polynucleotides encoding same
SG11201909777YA (en) Modulatory polynucleotides
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201809522WA (en) Method of nucleic acid sequence determination
SG11201910101SA (en) Alphavirus neoantigen vectors
SG11201804957VA (en) Neoantigen identification, manufacture, and use
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201907162TA (en) Methods for cell-type specific profiling to identify drug targets
SG11201811504PA (en) Single cell whole genome libraries and combinatorial indexing methods of making thereof
SG11201909914RA (en) Compositions and methods for improving sample identification in indexed nucleic acid libraries
SG11201903089RA (en) Aav delivery of nucleobase editors
SG11201810179RA (en) Novel crispr enzymes and systems
SG11201903021WA (en) Anti-human 4-1 bb antibodies and use thereof
SG11201901494UA (en) Acid-alpha glucosidase variants and uses thereof
SG11201806663TA (en) Closed-ended linear duplex dna for non-viral gene transfer
SG11201803593QA (en) Engineered nucleic-acid targeting nucleic acids
SG11201907889YA (en) Glycan-interacting compounds and methods of use
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201806845VA (en) Moisturizing compositions and uses thereof
SG11201903042VA (en) Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome
SG11201901633WA (en) 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
SG11201808964PA (en) Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene